Advertisement

Nitric Oxide in Arthritis: It’s Probably There But What’s It Doing?

  • C. H. Evans
  • M. Stefanovic-Racic
Conference paper
Part of the Ernst Schering Research Foundation Workshop book series (SCHERING FOUND, volume 21)

Abstract

Arthritis is a disease of diarthrodial joints. Although some forms of arthritis involve extraarticular tissues, the most prominent pathological lesions occur within the joints and all forms of arthritis produce articular inflammation or cartilage destruction or both. Patients with osteoarthritis (OA), for example, suffer considerable loss of cartilage with only low levels of inflammation, whereas the joints of patients with systemic lupus erythematosus (SLE; lupus) do not lose cartilage, despite being highly inflamed. Extensive cartilage loss and high levels of inflammation occur together in the joints of patients with rheumatoid arthritis (RA). In considering the possible roles of nitric oxide (NO) in arthritis, it is thus necessary to determine how NO influences both inflammation and cartilage erosion within joints. As these are distinct pathophysiological processes (Evans 1995a) they could respond differently to NO.

Keywords

Nitric Oxide Articular Cartilage Synovial Fluid Nitric Oxide Production Articular Chondrocytes 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aeberhard EE, Henderson SA, Arabolos NS, Griscavage JM, Castro FE, Barrett CT, Ignarro LJ (1995) Nonsteroidal anti-inflammatory drugs inhibit expression of the inducible nitric oxide synthase gene. Biochem Biophys Res Commun 208: 1053–1059PubMedCrossRefGoogle Scholar
  2. Albina JE, Abate JA, Henry WL (1991) Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation. Role of IFN-y in the induction of the nitric oxide-synthesizing pathway. J Immunol 147: 144–148Google Scholar
  3. Al-Ramadi, Meissler JJ, Huang D, Eisenstein TK (1992) Immunosuppression induced by nitric oxide and its inhibition by interleukin-4. Eur J Immunol 22: 2249–254PubMedCrossRefGoogle Scholar
  4. Amin AR, DiCesare PE, Vyas P, Attur M, Tzeng E, Billiar TR, Stuchin SA, Abramson SB (1995a) The expression and regulation of nitric oxide synthase in human osteoarthritis-affected chondrocytes: evidence for up-regulated neuronal nitric oxide synthase. J Exp Med 182: 2097–2102PubMedCrossRefGoogle Scholar
  5. Amin AR, Vyas P, Attur M, Leszczynska-Piziak J, Patel IR, Weissman G, Abramson SB (1995b) The mode of action of aspirin-like drugs: effect on inducible nitric oxide synthase. Proc Natl Acad Sci USA 92: 7926–7930PubMedCrossRefGoogle Scholar
  6. Blanco FJ, Lotz M (1995) IL-1-induced nitric oxide inhibits chondrocyte proliferation via PGE2. Exp Cell Res 218: 319–325PubMedCrossRefGoogle Scholar
  7. Blanco FJ, Ochs RL, Schwarz H, Lotz M (1995) Chondrocyte apoptosis induced by nitric oxide. Am J Pathol 146: 75–85PubMedGoogle Scholar
  8. Brown Z, Robson RL, Westwick J (1993) L-arginine/nitric oxide pathway: a possible signal transduction omechanism for the regulation of the chemokine IL-8 in human mesangial cells. In: Lindley IJD, Westwick J, Kunkel S (eds) The chemokines: biology of the inflammatory peptide supergene family II. Adv Exp Med Biol 351: 65–75Google Scholar
  9. Cannon GW, Remmers EF, Wilder RL, Hibbs JB, Griffiths MM (1995) Nitric oxide production during adjuvant-induced arthritis is associated with tumor necrosis factor genotype. Transplant Proc 27: 1543–1544PubMedGoogle Scholar
  10. Cannon GW, Openshaw SJ, Hibbs JB, Hoidal JR, Huecksteadt TP, Griffiths MM (1996) Nitric oxide production during adjuvant-induced and collagen-induced arthritis. Arthritis Rheum 39: 1677–1684PubMedCrossRefGoogle Scholar
  11. Cao M, Westerhausen-Larson A, Niyibizi C, Kavalkovich K, Georgescu HI, Rizzo CF, Hebda PA, Stefanovic-Racic M, Evans CH (1997) Nitric oxide inhibits the synthesis of type II collagen without altering COL2A I mRNA abundance: prolyl hydroxylase as a possible target. Biochem J 324: 305–310PubMedGoogle Scholar
  12. Charles IG, Palmer RMJ, Hickery MS, Bayliss MT, Chubb AP, Hall US, Moss DW, Moncada S (1993) Cloning, characterization and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte. Proc Natl Acad Sci USA 90: 11419–11423PubMedCrossRefGoogle Scholar
  13. Clancy RM, Abramson SB (1995) Nitric oxide: a novel mediator of inflammation. Proc Soc Exp Biol Med 210: 93–101PubMedGoogle Scholar
  14. Connor JR, Manning PT, Settle SL, Moore WM, Jerome GM, Webber RK, Tjoeng FS, Currie MG (1995) Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase. Eur J Pharmacol 273: 15–24PubMedCrossRefGoogle Scholar
  15. Curran RD, Billiar TR, Stuehr DJ, Hofmann K, Simmons RL (1989) Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells. J Exp Med 170: 1769–1774PubMedCrossRefGoogle Scholar
  16. Deakin AM, Payne AN, Whittle BJR, Moncada S (1995) The modulation of IL-6 and TNF-a release by nitric oxide following stimulation of J774 cells with LPS and IFN-y. Cytokine 7: 408–416PubMedCrossRefGoogle Scholar
  17. DeCaterina R, Libby P, Peng HB, Thannickai VJ, Rajavashisth TB, Gimbrone MA, Shin WS, Liao JK (1995) Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96: 60–68Google Scholar
  18. DiRosa M, Radomski M, Carnuccio R, Moncada S (1990) Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages. Biochem Biophys Res Commun 172: 1246–1252CrossRefGoogle Scholar
  19. Evans CH, Oppliger L, Michel BA, Stefanovic-Racic M, Tsao M, Larkin LA, Hauselman HJ (1994) Effect of nitric oxide on cytokine and prostaglandin synthesis by human articular cartilage (abstract). Osteoarthritis Cart 2: 51CrossRefGoogle Scholar
  20. Evans CH (1995a) Cartilage loss. In: Kuettner KE, Goldberg VM (eds) Osteoarthritic disorders. American Academy of Orthopaedic Surgeons, Rosemont, p 271Google Scholar
  21. Evans CH (1995b) Nitric oxide: what role does it play in inflammation and tissue destruction? In: Doherty NS, Weichman BM, Morgan DW, Marshall L (eds) Inflammation:mechanisms and therapeutics. Birkhäuser, Basel, p 107CrossRefGoogle Scholar
  22. Evans CH (1997) Synovium. In: Dee R (ed) Principles of orthopaedic practice, 2nd edn. McGraw-Hill, New York, pp 99–108Google Scholar
  23. Evans CH (1996) Nitric oxide and inflammation. In: Faist E, Baue AE, Schildberg FW (eds) The immune consequences of trauma, shock and sepsis. Pabst Science Publishers, Berlin, p 640 (Mechanisms and therapeutic approaches, vol 1 )Google Scholar
  24. Evans CH, Stefanovic-Racic M (1996) Nitric oxide in arthritis. Methods 10: 38–42PubMedCrossRefGoogle Scholar
  25. Evans CH, Watkins SC, Stefanovic-Racic M (1996) Nitric oxide and cartilage metabolism. Methods Enzymol 269: 75–88PubMedCrossRefGoogle Scholar
  26. Farrell AJ, Blake DR, Palmer RM, Moncada S (1992) Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 51: 1219–1222PubMedCrossRefGoogle Scholar
  27. Gauthier TW, Davenpeck KL, Lefer AM (1994) Nitric oxide attenuates leukocyte-endothelial interaction via P-selectin in splanchnic ischemia-reperfusion. Am J Physiol 267: G562 — G568PubMedGoogle Scholar
  28. Grabowski PS, Macpherson H, Ralston SH (1996a) Nitric oxide production in cells derived from the human joint. Br J Rheumatol 35: 207–212PubMedCrossRefGoogle Scholar
  29. Grabowski PS, England AJ, Dykhuizen R, Copland M, Benjamin N, Reid DM, Ralston SH (1996b) Elevated nitric oxide production in rheumatoid arthritis. Detection using the fasting urinary nitrate:creatinine ratio. Arthritis Rheum 39: 643–647PubMedCrossRefGoogle Scholar
  30. Gregory SH, Wing EJ, Hoffman RA, Simmons RL (1993) Reactive nitrogen intermediates suppress the primary immunological response to Listeria. J Immunol 150: 29901–2909Google Scholar
  31. Häuselmann HI, Oppliger L, Michel BA, Stefanovic-Racic M, Evans CH (1994) Nitric oxide and progteoglycan biosynthesis by human articular chondrocytes in alginate culture. FEBS Lett 352: 361–364PubMedCrossRefGoogle Scholar
  32. Häuselmann HJ, Flechtenmacher J, Michal L, Thonar EJMA, Shinmei M, Kuetner KE, Aydelote MB (1996) The superficial layer of human articular cartilage is more susceptible to interleukin-1 induced damage than the deeper layers. Arthritis Rheum 39: 478–488PubMedCrossRefGoogle Scholar
  33. Häuselmann HJ, Stefanovic-Racic M, Künzli S, Michel BA, Evans CH (1997) The role of nitric oxide in proteoglycan synthesis and catabolism by superficial and deep layers of human articular cartilage (submitted for publication )Google Scholar
  34. Holt PG, Oliver J, Bilyk N, McMenamim C, McMenamim PG, Kraal G, Thepen T (1993) Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages. J Exp Med 177: 397–407PubMedCrossRefGoogle Scholar
  35. Hung GL, Evans CH (1994) Synovium. In: Fu FH, Harper CD, Vince KG (eds) Knee surgery. Williams and Wilkins, Baltimore, pp 141–154Google Scholar
  36. Lalenti A, Moncada S, DiRosa M (1993) Modulation of adjuvant arthritis by endogenous nitric oxide. Br J Pharmacol 110: 701–706CrossRefGoogle Scholar
  37. Jacobs T, Morrell M, Manzi S, Verdile V, Simmons RL (1992) Elevated nitrates in inflammatory joint disease: nitric oxide in arthritis (abstract). Arthritis Rheum 35 [Suppl]: R9Google Scholar
  38. Jarvinen TAH, Moilanen T, Jarvinen TLN, Moilanen E (1995) Nitric oxide mediates interleukin-1 induced inhibition of glycosaminoglycan synthesis in rat articular cartilage. Med Inflamm 4: 107–112CrossRefGoogle Scholar
  39. Kaur H, Halliwell B (1994) Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett 350: 9–12Google Scholar
  40. Kuettner KE (1992) Biochemistry of articular cartilage in health and disease. Clin Biochem 25: 155–163PubMedCrossRefGoogle Scholar
  41. Kubes P (1992) Polymorphonuclear leukocyte-endothelium interactions: a role for pro-inflammatory and anti-inflammatory molecules. Can J Physiol Pharmacol 71: 88–97CrossRefGoogle Scholar
  42. Kubes P, Wallace JL (1995) Nitric oxide as a mediator of gastrointestinal mucosal injury? Say it ain’t so. Med Inflam 4: 397–405CrossRefGoogle Scholar
  43. Langrehr JM, Hoffman RA, Lancaster JR, Simmons RL (1993) Nitric oxide — a new endogenous immunomodulator. Transplantation 55: 1205–1212PubMedCrossRefGoogle Scholar
  44. Liew RH (1995) Regulation of lymphocyte functions by nitric oxide. Curr Opin Immunol 7: 396–399PubMedCrossRefGoogle Scholar
  45. Maier R, Bilbe G, Rediske J, Lotz M (1994) Inducible nitric oxide synthase from human articular chondrocytes: cDNA cloning and analysis of mRNA expression. Biochim Biophys Acta 1208: 145–150PubMedCrossRefGoogle Scholar
  46. Manfield L, Jang D, Murrell GAC (1996) Nitric oxide enhances cyclooxygenase activity in articular cartilage. Inflamm Res 45: 254–258PubMedCrossRefGoogle Scholar
  47. McCartney-Francis N, Allen JB, Mizel DE, Albina JE, Xie QW, Nathan CF, Wahl SM (1993) Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med 178: 749–754PubMedCrossRefGoogle Scholar
  48. Miesel R, Kurpisz M, Kroger H (1996) Suppression of inflammatory arthritis by simultaneous inhibition of nitric oxide synthase and NADPH oxidase. Free Radic Biol Med 20: 75–81PubMedCrossRefGoogle Scholar
  49. Miller MJS, Grisham MB (1995) Nitric oxide as a mediator of inflammation? You had better believe it. Med Inflam 4: 387–496CrossRefGoogle Scholar
  50. Moilanen E, Vapaatalo H (1995) Nitric oxide in inflammation and immune response. Ann Med 27: 359–367PubMedCrossRefGoogle Scholar
  51. Murrell GA, Jang D, Williams RI (1995) Nitric oxide activates metalloproteinase enzymes in articular cartilage. Biochem Biophys Res Commun 206: 15–21PubMedCrossRefGoogle Scholar
  52. Nussler AK, Billiar TR (1993) Inflammation, immunoregulation, and inducible nitric oxide synthase. J Leukoc Biol 54: 171–178PubMedGoogle Scholar
  53. Palmer RMJ, Andrews T, Fox well NA, Moncada S (1992) Glucocorticoids do not affect the induction of a novel calcium-dependent nitric oxide synthase in rabbit chondrocytes. Biochem Biophys Res Commun 188: 209–215PubMedCrossRefGoogle Scholar
  54. Palmer RMJ, Hickery MS, Charles IG, Moncada S, Bayliss MT (1993) Induction of nitric oxide synthase inhuman chondrocytes. Biochem Biophys Res Commun 193: 398–405PubMedCrossRefGoogle Scholar
  55. Pelletier JP, Mineau F, Rabger P, Tardif G, Martel-Pelletier J (1996) The increased synthesis of inducible nitric oxide inhibits IL-1Ra synthesis by human articular chondrocytes: possible role in osteoarthritic cartilage degradation. Osteoarthritis Cart 4: 77–84CrossRefGoogle Scholar
  56. Rediske JJ, Koehne CF, Zhang B, Lotz M (1994) The inducible production of nitric oxide by articular cell types. Osteoarthritis Cart 2: 199–206CrossRefGoogle Scholar
  57. Sakurai H, Kohsaka H, Liu MF, Higashiyama H, Hirata Y, Kanno K, Saito I, Miyasaka N (1995) Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J Clin Invest 96: 2357–2363PubMedCrossRefGoogle Scholar
  58. Salvemini DK, Misko TP, Masferrer JL, Seibert K, Curie MG, Needleman P (1993) Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 90: 7240–7244PubMedCrossRefGoogle Scholar
  59. Schumacher HR, Klippel JH, Koopman WJ (eds) (1993) Primer on the rheumatic diseases, 10th edn. Arthritis Foundation, AtlantaGoogle Scholar
  60. Seiler KP, Vavrin Z, Eichwald E, Hibbs JB, Weiss JJ (1995) Nitric oxide production during murine Lyme disease: lack of involvement in host resistance or pathology. Infect Immun 63: 3886–3895PubMedGoogle Scholar
  61. Sicher SC, Vazquez MA, Lu CY (1994) Inhibition of macrophage Ia expression by nitric oxide. J Immunol 153: 1293–1300PubMedGoogle Scholar
  62. Stadler J, Stefanovic-Racic M, Billiar TR, Curran RD, McIntyre LA, Georgescu HI, Simmons RL, Evans CH (1991) Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J Immunol 147: 3915–3920PubMedGoogle Scholar
  63. Stadler J, Harbrecht BG, DiSilvio M, Curran RD, Jordan ML, Simmons RL, Billiar TR (1993) Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin-6 by rat Kupffer cells. J Leukoc Biol 53: 165–172PubMedGoogle Scholar
  64. Stefanovic-Racic M, Stadler J, Evans CH (1993) Nitric oxide and arthritis. Arthritis Rheum 36: 1036–1044PubMedCrossRefGoogle Scholar
  65. Stefanovic-Racic M, Georgescu HI, Evans CH (1994a) Effects of anti-arthritic drugs upon the production of nitric oxide by rabbit synoviocytes and chondrocytes (abstract). Arthritis Rheum 37 [Supp1]: S386Google Scholar
  66. Stefanovic-Racic M, Stadler J, Georgescu HI, Evans CH (1994b) Nitric oxide and energy production in articular chondrocytes. J Cell Physiol 159: 274–280PubMedCrossRefGoogle Scholar
  67. Stefanovic-Racic M, Stadler J, Georgescu HI, Evans CH (1994c) Nitric oxide synthesis and its regulation by rabbit synoviocytes. J Rheumatol 21: 1892–1898PubMedGoogle Scholar
  68. Stefanovic-Racic M, Meyers K, Meschter C, Coffey JW, Hoffman RA, Evans CH (1995a) Comparison of the nitric oxide synthase inhibitors methylarginine and aminoguanidine as prophylactic and therapeutic agents in rat adjuvant arthritis. J Rheumatol 22: 1922–1928PubMedGoogle Scholar
  69. Stefanovic-Racic M, Taskiran D, Georgescu HI, Evans CH (1995b) Modulation of chondrocyte proteoglycan synthesis by endogenously produced nitric oxide. Inflamm Res 44 [Suppl 2]: S216 — S217PubMedCrossRefGoogle Scholar
  70. Stefanovic-Racic M, Morales TI, Taskiran D, McIntyre LA, Evans CH (1996) The role of nitric oxide in proteoglycan turnover by bovine articular cartilage organ cultures. J Immunol 156: 1213–1220PubMedGoogle Scholar
  71. Stefanovic-Racic M, Möllers M, Miller LA, Evans CH (1997) Nitric oxide and proteoglycan turnover in rabbit articular cartilage. J Orthop Res (In Press)Google Scholar
  72. Stichtenoth DO, Gutzki FM, Tsikas D, Selve N, Bode-Böger Sm, Böger RH, Fröhlich JC (1994) Increased urinary nitratte excretion in rats with adjuvant arthritis. Ann Rheum Dis 53: 547–549PubMedCrossRefGoogle Scholar
  73. Stichtenoth DO, Fauler J, Zeidler H, Frölich JC (1995a) Urinary nitrate excretion is increased in patients with rheumatoid arthritis and reduced by prednisolone. Ann Rheum Dis 54: 820–824PubMedCrossRefGoogle Scholar
  74. Strichtenoth DO, Wollenhaupt J, Andersone D, Zeidler H, Forlich JC (1995b) Elevated serum nitrate concentrations in active spondyloarthropathies. Br J Rheumatol 34: 616–619CrossRefGoogle Scholar
  75. Taskiran D, Stefanovic-Racic M, Georgescu H, Evans C (1994) Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin-1. Biochem Biophys Res Commun 200: 142–148PubMedCrossRefGoogle Scholar
  76. Taylor-Robinson AW, Liew FY, Severn A, Xu D, McSorley SJ, Garside P, Padron J, Phillips RS (1994) Regulation of the immune response by nitric oxide differentially produced by T helper type I and T helper type 2 cells. Eur J Immunol 24: 980–984PubMedCrossRefGoogle Scholar
  77. Ueki Y, Miyake S, Tominaga Y, Eguchi K (1996) Increased nitric oxide levels in patients with rheumatoid arthritis. J Rheumatol 23: 230–236PubMedGoogle Scholar
  78. Villarete LH, Remick DG (1995) Nitric oxide regulation of IL-8 expression in human endothelial cells. Biochem Biophys Res Commun 211: 671–676PubMedCrossRefGoogle Scholar
  79. Wei XQ, Charles IG, Smith A, Ure J, Feng GJ, Huang FP, Xu D, Muller W, Moncada S, Liew FY (1995) Altered immune responses in mice lacking indicible nitric oxide synthase. Nature 375: 408–411PubMedCrossRefGoogle Scholar
  80. Weinberg JB, Granger DL, Pisetsky DS, Seldin MF, Misukonis MA, Mason SN, Pippen AM, Ruiz P, Wood ER, Gildeson GS (1994) The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-1pr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine. J Exp Med 179: 651–660PubMedCrossRefGoogle Scholar
  81. Zidek Z, Frankova D, Otova B (1995) Lack of causal relationship between inducibility/severity of adjuvant arthritis in the rat and disease associated changes in production of nitric oxide by macrophages. Ann Rheum Dis 54: 325–327PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1997

Authors and Affiliations

  • C. H. Evans
  • M. Stefanovic-Racic

There are no affiliations available

Personalised recommendations